ESMO 2020: Osimertinib Reduces Central Nervous System Metastasis in Advanced Non-Small Cell Lung Cancer
Exploratory analysis of ADAURA trial supports use of osimertinib in adjuvant setting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.